Revised SPC: Imbruvica (ibrutinib) Film-Coated Tablets

SPC has been updated to note that cases of hepatitis E, which may be chronic, have occurred in patients treated with ibrutinib, and that patients should be monitored for abnormal liver function tests.

Source:

electronic Medicines compendium